Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWolf Minerals Regulatory News (WLFE)

  • There is currently no data for WLFE

Response to media speculation

27 Mar 2012 08:21

RNS Number : 1370A
Wolf Minerals Limited
27 March 2012
 



27 March 2012

 

Wolf Minerals Limited

 

Response to Media Speculation

 

Wolf Minerals Limited ("Wolf") has noted an article in The Times newspaper in London dated 26 March 2012, re-quoted in The Australian newspaper dated 27 March 2012, that indicated the company "is to embark on a £50 million fundraiser from equity investors in the coming weeks".

 

This comment is incorrect and should be regarded as media speculation by investors.

 

 

For further details, please contact:

 

Wolf Minerals Limited

Humphrey Hale

 

+61 8 6364 3776

Investec

Mark Wellesley-Wood/Neil Elliot

+44 20 7597 4000

 

Newgate Threadneedle

Beth Harris/Josh Royston

 

+44 (0) 20 7653 9850

 

 

About Wolf Minerals

 

Wolf Mineral is an ASX listed and AIM listed specialty minerals company focused on developing the world class Hemerdon Tungsten and Tin Project, in Devon, in the south-west of the UK. The Hemerdon project is 100% owned by Wolf and is one of the largest undeveloped tungsten and tin resources in the western world. It is ranked as the fourth largest tungsten deposit in the world in terms of contained tungsten metal, by The British Geological Survey. The Company aims to develop the project into a large scale, open pit mining operation, which will position it as a world class tungsten and tin producer. Wolf released a positive Definitive Feasibility Study for the Hemerdon project in May 2011, and it has updated planning permission for mining until 2021.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPCGRGDXSBDBGDR
Date   Source Headline
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:01 amRNSAppendix 3Y
30th Jun 20177:01 amRNSIssue of Equity and Change of Directors' Interests
29th Jun 20179:15 amRNSReplacement of Grant of ASX Listing Rule Waivers
28th Jun 20173:15 pmRNSASX Listing Waivers for Bridge Facility Increase
28th Jun 20173:15 pmRNSBridge Facility with RCF Increased
16th Jun 20177:00 amRNSIssue of Equity
16th Jun 20177:00 amRNSAppendix 3B
16th May 20177:00 amRNSCancellation of Lapsed Performance Rights
15th May 20179:05 amRNSAppendix 3Z
15th May 20179:05 amRNSResignation of Director
8th May 20177:00 amRNSAppendix 3X
8th May 20177:00 amRNSInterim MD, Richard Lucas, Appointed to Wolf Board
28th Apr 20177:00 amRNSQuarterly Activities Report
28th Apr 20177:00 amRNSAppendix 5B
7th Apr 201710:19 amRNSDirectorate Change
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSCleansing Notice Letter
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSIssue of Equity and Change of Directors' Interests
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3B
16th Mar 20177:02 amRNSInterim Financial Statements
13th Mar 20177:35 amRNSUpdate on Bridge Facility with RCF
20th Feb 20174:41 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
10th Feb 20179:20 amRNSCancellation of Lapsed Performance Rights
6th Feb 20177:00 amRNSRevised Securities Dealing Policy
31st Jan 20177:00 amRNSAppendix 5B
31st Jan 20177:00 amRNSQuarterly Activities Report
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3B
30th Dec 20168:10 amRNSCleansing Notice Letter
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:09 amRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20161:15 pmRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.